ASHLEY WOODS: Open Payments
NPI 1134903321 · GRENADA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 27 payments from 11 companies in 2025. Trend: 2023 $85 · 2024 $773 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| ABBVIE INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Corcept Therapeutics | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: MOUNJARO, Kerendia, AIRSUPRA, VRAYLAR, LEQVIO, Korlym, TRELEGY ELLIPTA, UBRELVY.
Industry payments across MS — which companies pay providers there.
